# Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC

> **NCT05484908** · NA · RECRUITING · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 60 (estimated)

## Conditions studied

- Immune-Mediated Hepatitis
- Liver Failure
- Hepatocellular Carcinoma

## Interventions

- **OTHER:** DPMAS+LPE
- **OTHER:** PE
- **OTHER:** Comprehensive internal medical treatment

## Key facts

- **NCT ID:** NCT05484908
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-12
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05484908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05484908, "Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05484908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*